• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Blindness and visual impairment decreasing worldwide

byAndrew Bishara
July 25, 2013
in Chronic Disease, Ophthalmology
Reading Time: 4 mins read
Blindness and visual impairment decreasing worldwide
Share on FacebookShare on Twitter

Image: PD

1. As of 2010, approximately 32 million people (0.5% of the world’s population) were blind, 60% of which were women. Most of these blind individuals were from South Asia (10.6 million), followed by East Asia (5.2 million) and Southeast Asia (3.5 million.)

2. Among older adults, blindness prevalence decreased from 3.0% in 1990 to 1.9% in 2010, while visual impairment decreased from 14.3% to 10.3%.

Evidence Rating Level: 2 (Good)

Study Rundown: This meta-analysis provides crucial information in identifying areas that still lack proper eye care and assessing the effect of interventions conducted worldwide. Most blind or visually impaired individuals are in South Asia, East Asia, or Southeast Asia, which is not surprising given the numerous developing nations in these areas. Visual impairment is more prevalent among women, which is surprising but could be related to access to care challenges in various parts of the world. While the prevalence of visual impairment decreased over 20 years, it did not decrease further than age-standardized prevalence; thus, the analysis demonstrates that while current global interventions to improve vision are successful, they need to be increased in order to compensate for the aging global population and overall population growth. Limitations of this analysis include the amount of estimation calculated based on statistical modeling; even age needed to be estimated from certain studies, especially for adults. Data on children were lacking, and many countries did not have data available. Nonetheless, this study serves as a valuable resource for assessing visual needs on a global scale.

Click to read the study in Ophthalmology

RELATED REPORTS

Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes

Tenecteplase not associated with visual improvement in central retinal artery occlusion

Ocular trauma may be a predictor of mortality in geriatric patients

Relevant Reading: Prevalence and Causes of Visual Field Loss in the Elderly and Associations With Impairment in Daily Functioning

In Depth [systematic review]: This meta-analysis attempted to estimate global prevalence of visual impairment and blindness while assessing changes in prevalence in various geographic areas from 1990 to 2010. Visual acuity data from 243 peer-reviewed studies were utilized to estimate the prevalence of blindness and visual impairment. Statistical regression models were then used to estimate these metrics by country, gender, age, and year. The study determined that as of 2010, approximately 32 million people (0.5% of the world’s population) were blind, 60% of which were women. Most of these blind individuals were from South Asia (10.6 million), followed by East Asia (5.2 million) and Southeast Asia (3.5 million.) An additional 2.8% of the world’s population (191 million) had significant visual impairment, 57% of which were women. In contrast, only 0.1% of North America’s population was blind and 0.9% of North Americans had visual impairment. Vision loss mostly affected those older than 50 (77% and 85% of the blindness and visual impairment population respectively). Geographical prevalence of blindness was highest in sub-Saharan Africa, South Asia, and North Africa with more than 50% of the world’s blind population in 5 countries – India, China, Indonesia, Pakistan, and Nigeria. Among older adults, blindness prevalence decreased from 3.0% in 1990 to 1.9% in 2010, while visual impairment decreased from 14.3% to 10.3%. These decreases were lower than expected, given the higher proportion of older adults in the world population.

By Swarup Swaminathan and Andrew Bishara

More from this author: Visual impairment is increasing among American adults, Contact lens sensor allows for continuous intraocular pressure monitoring, Conventional Wnt signaling pathway is a potential new target for glaucoma therapeutics, Inhibition of molecular signaling in injured cornea hastens cell migration and wound closure, New point of care test highly sensitive and specific for adenoviral conjunctivitis, Argus II retinal prosthesis significantly improves spatial vision in blind patients, Artificial cornea is well retained in patients with ocular surface disease, High prevalence of undiagnosed glaucoma in West Africa, Interferon therapy is superior to methotrexate for uveitis, Rho kinase inhibitor safely reduces intraocular pressure

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. 

Tags: blindnessOphthalmologysystemic reviewvisual acuityvisually impaired
Previous Post

Physical examination sufficient to evaluate abdominal stab wounds

Next Post

Clinical impression not reliable in identifying drug-seeking behavior

RelatedReports

Adalimumab aids in control of noninfectious uveitis
Chronic Disease

Cataract surgery is associated with increased incidence of diabetic retinopathy among patients with diabetes

September 8, 2026
siRNA against antithrombin alleviates symptoms of hemophilia [PreClinical]
Neurology

Tenecteplase not associated with visual improvement in central retinal artery occlusion

January 28, 2026
Quick Take: Association of Visual Impairment With Economic Development Among Chinese Schoolchildren
Chronic Disease

Ocular trauma may be a predictor of mortality in geriatric patients

June 2, 2025
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Chronic Disease

Personalized visual perceptual learning digital therapy may improve vision post-stroke

May 30, 2025
Next Post
Clinical impression not reliable in identifying drug-seeking behavior

Clinical impression not reliable in identifying drug-seeking behavior

Exercise associated with lower pain ratings

Limited cardiovascular effect of diet and exercise in obese type II diabetics

Antidepressant may reduce mental stress-induced myocardial ischemia (REMIT Trial)

For ischemic mitral regurgitation, less surgery yields comparable results

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Brepocitinib becomes first oral therapy approved for adult dermatomyositis
  • An ultrasound-guided percutaneous method of vagal nerve stimulation may be effective for refractory chronic pain
  • Daraxonrasib extends survival in metastatic pancreatic cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.